Kabidarba 25mcg Injection
Marketer
Fresenius Kabi India Pvt Ltd
Salt Composition
Darbepoetin alfa (25mcg)
Overview Kabidarba 25mcg Injection
Erythropoietin alfa (25mcg injection) is indicated for anemia resulting from chronic kidney disease or chemotherapy. Its mechanism involves bone marrow stimulation, increasing red blood cell production. This medication requires careful administration due to the potential for severe adverse reactions; treatment should be managed by a physician experienced in its use, with strict adherence to their instructions. Administration is always under medical supervision. Frequently reported side effects include abdominal discomfort, hypertension, skin rash, injection site pain, dyspnea, cough, and peripheral edema. Report symptoms of severe hypertension immediately (intense headache, visual disturbances, nausea, vomiting, or convulsions). Regular blood tests will monitor electrolyte levels (potassium), hemoglobin, and complete blood count. Discontinue use and seek medical attention if shortness of breath or a skin rash develops. Prior to commencing treatment, disclose any history of cardiac disease, hypertension, seizures, or stroke. Pregnant, breastfeeding, or intending to conceive or breastfeed individuals should consult their physician regarding its safety.
Uses of Kabidarba 25mcg Injection
Managing anemia associated with chronic kidney failure | Addressing anemia caused by cancer treatments
Major Benefits of Kabidarba 25mcg Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
Common Side effects of Kabidarba 25mcg Injection:
- Abdominal pain
- High blood pressure
- Rash
- Injection site pain
- Breathlessness
- Cough
- Peripheral edema
- Procedural hypotension (low blood pressure)
- Convulsion
- Thromboembolism
How to use Kabidarba 25mcg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Kabidarba 25mcg Injection works:
Kabidarba 25mcg Injection, an erythropoietin-based medication, boosts red blood cell production. This action is achieved by stimulating increased red blood cell synthesis within the bone marrow, the blood-cell-forming tissue located inside bones.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Kabidarba 25mcg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Kabidarba 25mcg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Administration of Kabidarba 25mcg Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Kabidarba 25mcg Injection.
KidneySAFE IF PRESCRIBED
Kabidarba 25mcg Injection poses no safety concerns for patients with renal impairment; dose modification is unnecessary.
LiverCAUTION
Patients with liver impairment should use Kabidarba 25mcg Injection cautiously, as dose modification may be necessary. Physician consultation is advised.
What if you forget to take Kabidarba 25mcg Injection :
Should you forget a dose of Kabidarba 25mcg Injection, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Kabidarba 25mcg Injection
| Label | Value |
|---|---|
| Chemical Classification | Amino Acid and Peptide Analogs |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | Erythropoietin-stimulating drug |
3,018 People bought this recently